Recursion Pharmaceuticals, Inc. - Class A Common Stock — Balance Sheet (NASDAQ:RXRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 610.35 M701.29 M653.7 M1.45 B1.47 B Total liabilities 67.41 M215.48 M190.26 M413.82 M343.26 M Total equity 542.94 M485.81 M463.44 M1.03 B1.13 B Total liabilities & shareholders' equities 610.35 M701.29 M653.7 M1.45 B1.47 B Total debt 723 K633 K1.14 M—— Net debt -515.84 M-549.28 M-390.42 M——

News

Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market

3 Cancer Stocks to Watch as Oncology Innovation Accelerates

CRCL, COIN, SOFI: Cathie Wood Ends June by Buying the Dip in Crypto and Fintech Stocks, While Selling Two Big Winners - TipRanks.com

BABA, COIN, PLTR, SPCX: Cathie Wood Dumps $54 Million of Alibaba Stock, Buys More Coinbase, Palantir and SpaceX - TipRanks.com

Recursion Pharmaceuticals (RXRX) Ascends While Market Falls: Some Facts to Note

1 of the Most Interesting AI Stocks in the Market Isn’t a Tech Company

AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL)

Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today

Recursion Pharmaceuticals: Short-Trade Crowded But Near-Term Squeeze Not Guaranteed (RXRX)

Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report?

Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know

Recursion Pharmaceuticals, Inc. (RXRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript